These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

308 related items for PubMed ID: 2569034

  • 1. Characteristics and distribution of receptors for [D-TRP6]-luteinizing hormone-releasing hormone, somatostatin, epidermal growth factor, and sex steroids in 500 biopsy samples of human breast cancer.
    Fekete M, Wittliff JL, Schally AV.
    J Clin Lab Anal; 1989; 3(3):137-47. PubMed ID: 2569034
    [Abstract] [Full Text] [Related]

  • 2. Receptors for luteinizing hormone-releasing hormone, somatostatin, prolactin, and epidermal growth factor in rat and human prostate cancers and in benign prostate hyperplasia.
    Fekete M, Redding TW, Comaru-Schally AM, Pontes JE, Connelly RW, Srkalovic G, Schally AV.
    Prostate; 1989; 14(3):191-208. PubMed ID: 2471961
    [Abstract] [Full Text] [Related]

  • 3. Receptors for D-Trp6-luteinizing hormone-releasing hormone, somatostatin, and insulin-like growth factor I in MXT mouse mammary carcinoma.
    Srkalovic G, Szende B, Redding TW, Groot K, Schally AV.
    Proc Soc Exp Biol Med; 1989 Dec; 192(3):209-18. PubMed ID: 2574866
    [Abstract] [Full Text] [Related]

  • 4. Presence of membrane binding sites for [D-TRP6]-luteinizing hormone-releasing hormone in experimental pancreatic cancer.
    Fekete M, Zalatnai A, Schally AV.
    Cancer Lett; 1989 May; 45(2):87-91. PubMed ID: 2567204
    [Abstract] [Full Text] [Related]

  • 5. Membrane receptors for peptides in experimental and human pancreatic cancers.
    Fekete M, Zalatnai A, Comaru-Schally AM, Schally AV.
    Pancreas; 1989 May; 4(5):521-8. PubMed ID: 2573055
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of binding of cytotoxic analogs of luteinizing hormone-releasing hormone to human breast cancer and mouse MXT mammary tumor.
    Milovanovic SR, Radulovic S, Schally AV.
    Breast Cancer Res Treat; 1992 May; 24(2):147-58. PubMed ID: 8443402
    [Abstract] [Full Text] [Related]

  • 7. Detection and partial characterization of receptors for [D-Trp6]-luteinizing hormone-releasing hormone and epidermal growth factor in human endometrial carcinoma.
    Srkalovic G, Wittliff JL, Schally AV.
    Cancer Res; 1990 Mar 15; 50(6):1841-6. PubMed ID: 2155060
    [Abstract] [Full Text] [Related]

  • 8. Receptors for prolactin, somatostatin, and luteinizing hormone-releasing hormone in experimental prostate cancer after treatment with analogs of luteinizing hormone-releasing hormone and somatostatin.
    Kadar T, Redding TW, Ben-David M, Schally AV.
    Proc Natl Acad Sci U S A; 1988 Feb 15; 85(3):890-4. PubMed ID: 2893378
    [Abstract] [Full Text] [Related]

  • 9. Presence and characteristics of receptors for [D-Trp6]luteinizing hormone releasing hormone and epidermal growth factor in human ovarian cancer.
    Srkalovic G, Schally AV, Wittliff JL, Day TG, Jenison EL.
    Int J Oncol; 1998 Mar 15; 12(3):489-98. PubMed ID: 9472084
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of growth of PC-82 human prostate cancer line xenografts in nude mice by bombesin antagonist RC-3095 or combination of agonist [D-Trp6]-luteinizing hormone-releasing hormone and somatostatin analog RC-160.
    Milovanovic SR, Radulovic S, Groot K, Schally AV.
    Prostate; 1992 Mar 15; 20(4):269-80. PubMed ID: 1376910
    [Abstract] [Full Text] [Related]

  • 11. Effect of treatment with LHRH analogs containing cytotoxic radicals on the binding characteristics of receptors for luteinizing-hormone-releasing hormone in MXT mouse mammary carcinoma.
    Milovanovic SR, Monje E, Szepeshazi K, Radulovic S, Schally A.
    J Cancer Res Clin Oncol; 1993 Mar 15; 119(5):273-8. PubMed ID: 8382705
    [Abstract] [Full Text] [Related]

  • 12. Down-regulation and change in subcellular distribution of receptors for luteinizing hormone-releasing hormone in OV-1063 human epithelial ovarian cancers during therapy with LH-RH antagonist Cetrorelix.
    Halmos G, Schally AV, Kahan Z.
    Int J Oncol; 2000 Aug 15; 17(2):367-73. PubMed ID: 10891548
    [Abstract] [Full Text] [Related]

  • 13. Effects of epidermal growth factor and analogues of luteinizing hormone-releasing hormone and somatostatin on phosphorylation and dephosphorylation of tyrosine residues of specific protein substrates in various tumors.
    Lee MT, Liebow C, Kamer AR, Schally AV.
    Proc Natl Acad Sci U S A; 1991 Mar 01; 88(5):1656-60. PubMed ID: 1672042
    [Abstract] [Full Text] [Related]

  • 14. Decrease in the level and mRNA expression of LH-RH and EGF receptors after treatment with LH-RH antagonist cetrorelix in DU-145 prostate tumor xenografts in nude mice.
    Lamharzi N, Halmos G, Jungwirth A, Schally AV.
    Int J Oncol; 1998 Sep 01; 13(3):429-35. PubMed ID: 9683774
    [Abstract] [Full Text] [Related]

  • 15. Growth inhibition of estrogen independent MXT mouse mammary carcinomas in mice treated with an agonist or antagonist of LH-RH, an analog of somatostatin, or a combination.
    Szepeshazi K, Milovanovic S, Lapis K, Groot K, Schally AV.
    Breast Cancer Res Treat; 1992 Sep 01; 21(3):181-92. PubMed ID: 1355375
    [Abstract] [Full Text] [Related]

  • 16. Inhibitory effects of analogs of luteinizing hormone-releasing hormone on the growth of the androgen-independent Dunning R-3327-AT-1 rat prostate cancer.
    Pinski J, Reile H, Halmos G, Groot K, Schally AV.
    Int J Cancer; 1994 Oct 01; 59(1):51-5. PubMed ID: 7927904
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of human epithelial ovarian cancer cell growth in vitro by agonistic and antagonistic analogues of luteinizing hormone-releasing hormone.
    Yano T, Pinski J, Radulovic S, Schally AV.
    Proc Natl Acad Sci U S A; 1994 Mar 01; 91(5):1701-5. PubMed ID: 8127868
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of mammary tumor growth in rats and mice by administration of agonistic and antagonistic analogs of luteinizing hormone-releasing hormone.
    Redding TW, Schally AV.
    Proc Natl Acad Sci U S A; 1983 Mar 01; 80(5):1459-62. PubMed ID: 6219395
    [Abstract] [Full Text] [Related]

  • 19. Somatostatin analogs as adjuncts to agonists of luteinizing hormone-releasing hormone in the treatment of experimental prostate cancer.
    Schally AV, Redding TW.
    Proc Natl Acad Sci U S A; 1987 Oct 01; 84(20):7275-9. PubMed ID: 2890164
    [Abstract] [Full Text] [Related]

  • 20. The relationship between somatostatin, epidermal growth factor, and steroid hormone receptors in breast cancer.
    Reubi JC, Torhorst J.
    Cancer; 1989 Sep 15; 64(6):1254-60. PubMed ID: 2569925
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.